| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| gsk-356278 | phosphodiesterase 4a | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Huntington Disease[MeSHID:D006816] |
0.68 | phase 1 | unknown |
| gsk-356278 | phosphodiesterase 4b | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Huntington Disease[MeSHID:D006816] |
0.64 | phase 1 | unknown |
| gsk-356278 | phosphodiesterase 4d | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Huntington Disease[MeSHID:D006816] |
0.71 | phase 1 | unknown |
| click here to return to the previous page | ||||||||